CTOs on the Move

Agendia USA

www.agendia.com

 
Agendia is a precision oncology company headquartered in Irvine, California, committed to bringing patients with early stage breast cancer and their physicians the information they need to make the best decisions for the full treatment journey. The company currently offers two commercially-available genomic profiling tests, supported by the highest levels of clinical and real world evidence, that provide comprehensive genomic information that can be used to identify the most effective breast cancer treatment possible for each patient. MammaPrint®, the 70-gene breast cancer recurrence assay, is the only FDA-cleared risk of recurrence test backed by peer-reviewed, prospective outcome data and inclusion in ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

DiLab

DiLab is a Littleton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Corgenix Medical Corporation

Corgenix Medical Corporation is a Broomfield, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Zwanger-Pesiri Radiology Group

Zwanger-Pesiri Radiology Group is a Lindenhurst, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Evexia Diagnostics

Evexia Diagnostics provides comprehensive, cutting-edge, clinical laboratory services at unbeatable prices with a focus on the Functional Medicine and Integrative Medicine, cash-based practice.

Emerge

Emerge Clinical Decision Solutions, a leader in the cardiology technology world, engineers software developed by leading cardiologists to help medical providers and administrators improve care. The software leverages a patented algorithm to analyze more than 8,000 unique data points in seconds and help alert doctors of any missed information, suggest specific tests and outline appropriate care paths. By helping doctors pinpoint conditions that are traditionally more difficult to diagnose, Emerge is helping patients receive the right care at the right time before costly, stressful emergency visits become necessary. The software has been proven to increase identification of certain cardiac diseases by as much as 300 percent.